Health Products

Vyvanse Capsule (2019-08-08)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III

Summary

Product

Vyvanse 20 mg Capsule

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
AG4982BVyvanse 20 mg Capsule
Recalling Firm
Shire Pharma Canada ULC
22 Adelaide St West, Suite 3800
Toronto
M5H 4E3
Ontario
CANADA
Marketing Authorization Holder
Shire Pharma Canada ULC
22 Adelaide St West, Suite 3800
Toronto
M5H 4E3
Ontario
CANADA
CapsuleDIN 02347156Lisdexamfetamine dimesylate 20 mg

Reason

The dissolution in the affected lot is out of specification.

Depth of distribution

Wholesalers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime